Mild or Moderate Covid-19

N Engl J Med. 2020 Oct 29;383(18):1757-1766. doi: 10.1056/NEJMcp2009249. Epub 2020 Apr 24.

Authors

Rajesh T Gandhi¹, John B Lynch¹, Carlos Del Rio¹

Affiliation

¹ From Massachusetts General Hospital and Harvard Medical School, Boston (R.T.G.); the Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle (J.B.L.); and the Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, and Grady Health System, Atlanta (C.R.).

PMID: 32329974
DOI: 10.1056/NEJMcp2009249

No abstract available

Publication types

Review

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections / diagnosis*
Coronavirus Infections / drug therapy
Coronavirus Infections / prevention & control
Humans
Pandemics / prevention & control
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / drug therapy
Pneumonia, Viral / prevention & control
Practice Guidelines as Topic
SARS-CoV-2
Severity of Illness Index
Symptom Assessment*